nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—Enuresis—Donepezil—Alzheimer's disease	0.0537	0.0618	CcSEcCtD
Thiabendazole—Lansoprazole—MAPT—Alzheimer's disease	0.0412	0.892	CrCbGaD
Thiabendazole—Epigastric distress—Donepezil—Alzheimer's disease	0.0396	0.0456	CcSEcCtD
Thiabendazole—Visual acuity reduced—Memantine—Alzheimer's disease	0.0234	0.027	CcSEcCtD
Thiabendazole—Numbness—Donepezil—Alzheimer's disease	0.0185	0.0213	CcSEcCtD
Thiabendazole—Sensory loss—Donepezil—Alzheimer's disease	0.0177	0.0204	CcSEcCtD
Thiabendazole—Numbness—Memantine—Alzheimer's disease	0.0168	0.0194	CcSEcCtD
Thiabendazole—Sensory loss—Memantine—Alzheimer's disease	0.0161	0.0185	CcSEcCtD
Thiabendazole—Coordination abnormal—Memantine—Alzheimer's disease	0.0142	0.0163	CcSEcCtD
Thiabendazole—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.0139	0.016	CcSEcCtD
Thiabendazole—Lymphadenopathy—Rivastigmine—Alzheimer's disease	0.0116	0.0134	CcSEcCtD
Thiabendazole—Hepatic failure—Memantine—Alzheimer's disease	0.0113	0.013	CcSEcCtD
Thiabendazole—Hyperglycaemia—Galantamine—Alzheimer's disease	0.0112	0.0129	CcSEcCtD
Thiabendazole—Haematuria—Galantamine—Alzheimer's disease	0.0106	0.0122	CcSEcCtD
Thiabendazole—Visual impairment—Galantamine—Alzheimer's disease	0.00959	0.011	CcSEcCtD
Thiabendazole—Tinnitus—Galantamine—Alzheimer's disease	0.00928	0.0107	CcSEcCtD
Thiabendazole—Flushing—Galantamine—Alzheimer's disease	0.00924	0.0106	CcSEcCtD
Thiabendazole—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00869	0.01	CcSEcCtD
Thiabendazole—Jaundice—Donepezil—Alzheimer's disease	0.00837	0.00964	CcSEcCtD
Thiabendazole—Haematuria—Donepezil—Alzheimer's disease	0.00819	0.00943	CcSEcCtD
Thiabendazole—Vision blurred—Galantamine—Alzheimer's disease	0.00816	0.0094	CcSEcCtD
Thiabendazole—Hyperglycaemia—Memantine—Alzheimer's disease	0.00789	0.00908	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00773	0.0089	CcSEcCtD
Thiabendazole—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00772	0.00888	CcSEcCtD
Thiabendazole—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00767	0.00883	CcSEcCtD
Thiabendazole—Drowsiness—Rivastigmine—Alzheimer's disease	0.00763	0.00878	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00757	0.00871	CcSEcCtD
Thiabendazole—Convulsion—Galantamine—Alzheimer's disease	0.00751	0.00864	CcSEcCtD
Thiabendazole—Haematuria—Memantine—Alzheimer's disease	0.00744	0.00856	CcSEcCtD
Thiabendazole—Visual impairment—Donepezil—Alzheimer's disease	0.00743	0.00855	CcSEcCtD
Thiabendazole—Haematuria—Rivastigmine—Alzheimer's disease	0.00728	0.00837	CcSEcCtD
Thiabendazole—Tinnitus—Donepezil—Alzheimer's disease	0.00719	0.00828	CcSEcCtD
Thiabendazole—Confusional state—Galantamine—Alzheimer's disease	0.00713	0.0082	CcSEcCtD
Thiabendazole—Hypoaesthesia—Memantine—Alzheimer's disease	0.00697	0.00802	CcSEcCtD
Thiabendazole—Chills—Donepezil—Alzheimer's disease	0.00692	0.00796	CcSEcCtD
Thiabendazole—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00682	0.00784	CcSEcCtD
Thiabendazole—Visual impairment—Memantine—Alzheimer's disease	0.00675	0.00777	CcSEcCtD
Thiabendazole—Anorexia—Galantamine—Alzheimer's disease	0.00674	0.00776	CcSEcCtD
Thiabendazole—Erythema multiforme—Memantine—Alzheimer's disease	0.00662	0.00762	CcSEcCtD
Thiabendazole—Hypotension—Galantamine—Alzheimer's disease	0.00661	0.0076	CcSEcCtD
Thiabendazole—Visual impairment—Rivastigmine—Alzheimer's disease	0.0066	0.0076	CcSEcCtD
Thiabendazole—Tinnitus—Memantine—Alzheimer's disease	0.00653	0.00751	CcSEcCtD
Thiabendazole—Flushing—Memantine—Alzheimer's disease	0.0065	0.00748	CcSEcCtD
Thiabendazole—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00648	0.00745	CcSEcCtD
Thiabendazole—Tinnitus—Rivastigmine—Alzheimer's disease	0.00639	0.00735	CcSEcCtD
Thiabendazole—Flushing—Rivastigmine—Alzheimer's disease	0.00636	0.00732	CcSEcCtD
Thiabendazole—Vision blurred—Donepezil—Alzheimer's disease	0.00633	0.00728	CcSEcCtD
Thiabendazole—Somnolence—Galantamine—Alzheimer's disease	0.00629	0.00723	CcSEcCtD
Thiabendazole—Chills—Memantine—Alzheimer's disease	0.00628	0.00723	CcSEcCtD
Thiabendazole—Dyspepsia—Galantamine—Alzheimer's disease	0.00622	0.00716	CcSEcCtD
Thiabendazole—Chills—Rivastigmine—Alzheimer's disease	0.00615	0.00707	CcSEcCtD
Thiabendazole—Decreased appetite—Galantamine—Alzheimer's disease	0.00615	0.00707	CcSEcCtD
Thiabendazole—Fatigue—Galantamine—Alzheimer's disease	0.0061	0.00701	CcSEcCtD
Thiabendazole—Feeling abnormal—Galantamine—Alzheimer's disease	0.00583	0.0067	CcSEcCtD
Thiabendazole—Convulsion—Donepezil—Alzheimer's disease	0.00582	0.00669	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00578	0.00665	CcSEcCtD
Thiabendazole—Vision blurred—Memantine—Alzheimer's disease	0.00574	0.00661	CcSEcCtD
Thiabendazole—Vision blurred—Rivastigmine—Alzheimer's disease	0.00562	0.00647	CcSEcCtD
Thiabendazole—Abdominal pain—Galantamine—Alzheimer's disease	0.00559	0.00643	CcSEcCtD
Thiabendazole—Confusional state—Donepezil—Alzheimer's disease	0.00552	0.00636	CcSEcCtD
Thiabendazole—Leukopenia—Memantine—Alzheimer's disease	0.00546	0.00628	CcSEcCtD
Thiabendazole—Convulsion—Memantine—Alzheimer's disease	0.00528	0.00608	CcSEcCtD
Thiabendazole—Anorexia—Donepezil—Alzheimer's disease	0.00522	0.00601	CcSEcCtD
Thiabendazole—Hypersensitivity—Galantamine—Alzheimer's disease	0.00521	0.00599	CcSEcCtD
Thiabendazole—Convulsion—Rivastigmine—Alzheimer's disease	0.00517	0.00595	CcSEcCtD
Thiabendazole—Hypotension—Donepezil—Alzheimer's disease	0.00512	0.00589	CcSEcCtD
Thiabendazole—Asthenia—Galantamine—Alzheimer's disease	0.00507	0.00584	CcSEcCtD
Thiabendazole—Confusional state—Memantine—Alzheimer's disease	0.00502	0.00577	CcSEcCtD
Thiabendazole—Lansoprazole—CYP2D6—Alzheimer's disease	0.005	0.108	CrCbGaD
Thiabendazole—Confusional state—Rivastigmine—Alzheimer's disease	0.00491	0.00565	CcSEcCtD
Thiabendazole—Somnolence—Donepezil—Alzheimer's disease	0.00487	0.00561	CcSEcCtD
Thiabendazole—Diarrhoea—Galantamine—Alzheimer's disease	0.00484	0.00557	CcSEcCtD
Thiabendazole—Dyspepsia—Donepezil—Alzheimer's disease	0.00482	0.00555	CcSEcCtD
Thiabendazole—Decreased appetite—Donepezil—Alzheimer's disease	0.00476	0.00548	CcSEcCtD
Thiabendazole—Anorexia—Memantine—Alzheimer's disease	0.00474	0.00546	CcSEcCtD
Thiabendazole—Fatigue—Donepezil—Alzheimer's disease	0.00472	0.00544	CcSEcCtD
Thiabendazole—Dizziness—Galantamine—Alzheimer's disease	0.00468	0.00538	CcSEcCtD
Thiabendazole—Hypotension—Memantine—Alzheimer's disease	0.00465	0.00535	CcSEcCtD
Thiabendazole—Anorexia—Rivastigmine—Alzheimer's disease	0.00464	0.00534	CcSEcCtD
Thiabendazole—Hypotension—Rivastigmine—Alzheimer's disease	0.00455	0.00523	CcSEcCtD
Thiabendazole—Feeling abnormal—Donepezil—Alzheimer's disease	0.00452	0.0052	CcSEcCtD
Thiabendazole—Vomiting—Galantamine—Alzheimer's disease	0.0045	0.00517	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00448	0.00516	CcSEcCtD
Thiabendazole—Rash—Galantamine—Alzheimer's disease	0.00446	0.00513	CcSEcCtD
Thiabendazole—Dermatitis—Galantamine—Alzheimer's disease	0.00445	0.00513	CcSEcCtD
Thiabendazole—Headache—Galantamine—Alzheimer's disease	0.00443	0.0051	CcSEcCtD
Thiabendazole—Somnolence—Memantine—Alzheimer's disease	0.00442	0.00509	CcSEcCtD
Thiabendazole—Dyspepsia—Memantine—Alzheimer's disease	0.00438	0.00504	CcSEcCtD
Thiabendazole—Abdominal pain—Donepezil—Alzheimer's disease	0.00433	0.00498	CcSEcCtD
Thiabendazole—Somnolence—Rivastigmine—Alzheimer's disease	0.00433	0.00498	CcSEcCtD
Thiabendazole—Decreased appetite—Memantine—Alzheimer's disease	0.00432	0.00498	CcSEcCtD
Thiabendazole—Fatigue—Memantine—Alzheimer's disease	0.00429	0.00494	CcSEcCtD
Thiabendazole—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00428	0.00493	CcSEcCtD
Thiabendazole—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00423	0.00487	CcSEcCtD
Thiabendazole—Nausea—Galantamine—Alzheimer's disease	0.0042	0.00483	CcSEcCtD
Thiabendazole—Fatigue—Rivastigmine—Alzheimer's disease	0.0042	0.00483	CcSEcCtD
Thiabendazole—Feeling abnormal—Memantine—Alzheimer's disease	0.0041	0.00472	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00407	0.00468	CcSEcCtD
Thiabendazole—Hypersensitivity—Donepezil—Alzheimer's disease	0.00404	0.00465	CcSEcCtD
Thiabendazole—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00401	0.00462	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00398	0.00458	CcSEcCtD
Thiabendazole—Abdominal pain—Memantine—Alzheimer's disease	0.00393	0.00453	CcSEcCtD
Thiabendazole—Asthenia—Donepezil—Alzheimer's disease	0.00393	0.00452	CcSEcCtD
Thiabendazole—Pruritus—Donepezil—Alzheimer's disease	0.00388	0.00446	CcSEcCtD
Thiabendazole—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00385	0.00443	CcSEcCtD
Thiabendazole—Diarrhoea—Donepezil—Alzheimer's disease	0.00375	0.00431	CcSEcCtD
Thiabendazole—Hypersensitivity—Memantine—Alzheimer's disease	0.00367	0.00422	CcSEcCtD
Thiabendazole—Dizziness—Donepezil—Alzheimer's disease	0.00362	0.00417	CcSEcCtD
Thiabendazole—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00359	0.00413	CcSEcCtD
Thiabendazole—Asthenia—Memantine—Alzheimer's disease	0.00357	0.00411	CcSEcCtD
Thiabendazole—CYP1A1—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.00355	0.0418	CbGpPWpGaD
Thiabendazole—Pruritus—Memantine—Alzheimer's disease	0.00352	0.00405	CcSEcCtD
Thiabendazole—Asthenia—Rivastigmine—Alzheimer's disease	0.00349	0.00402	CcSEcCtD
Thiabendazole—Vomiting—Donepezil—Alzheimer's disease	0.00348	0.00401	CcSEcCtD
Thiabendazole—Rash—Donepezil—Alzheimer's disease	0.00345	0.00398	CcSEcCtD
Thiabendazole—Dermatitis—Donepezil—Alzheimer's disease	0.00345	0.00397	CcSEcCtD
Thiabendazole—Pruritus—Rivastigmine—Alzheimer's disease	0.00344	0.00396	CcSEcCtD
Thiabendazole—Headache—Donepezil—Alzheimer's disease	0.00343	0.00395	CcSEcCtD
Thiabendazole—Diarrhoea—Memantine—Alzheimer's disease	0.0034	0.00392	CcSEcCtD
Thiabendazole—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00333	0.00383	CcSEcCtD
Thiabendazole—Dizziness—Memantine—Alzheimer's disease	0.00329	0.00379	CcSEcCtD
Thiabendazole—Nausea—Donepezil—Alzheimer's disease	0.00325	0.00375	CcSEcCtD
Thiabendazole—Dizziness—Rivastigmine—Alzheimer's disease	0.00322	0.0037	CcSEcCtD
Thiabendazole—Vomiting—Memantine—Alzheimer's disease	0.00316	0.00364	CcSEcCtD
Thiabendazole—Rash—Memantine—Alzheimer's disease	0.00314	0.00361	CcSEcCtD
Thiabendazole—Dermatitis—Memantine—Alzheimer's disease	0.00313	0.00361	CcSEcCtD
Thiabendazole—Headache—Memantine—Alzheimer's disease	0.00312	0.00359	CcSEcCtD
Thiabendazole—Vomiting—Rivastigmine—Alzheimer's disease	0.00309	0.00356	CcSEcCtD
Thiabendazole—Rash—Rivastigmine—Alzheimer's disease	0.00307	0.00353	CcSEcCtD
Thiabendazole—Dermatitis—Rivastigmine—Alzheimer's disease	0.00307	0.00353	CcSEcCtD
Thiabendazole—Headache—Rivastigmine—Alzheimer's disease	0.00305	0.00351	CcSEcCtD
Thiabendazole—Nausea—Memantine—Alzheimer's disease	0.00295	0.0034	CcSEcCtD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—MAP2—Alzheimer's disease	0.00295	0.0348	CbGpPWpGaD
Thiabendazole—Nausea—Rivastigmine—Alzheimer's disease	0.00289	0.00333	CcSEcCtD
Thiabendazole—CYP1A1—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.00246	0.029	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.00245	0.0288	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.00226	0.0267	CbGpPWpGaD
Thiabendazole—CYP1A1—Xenobiotics—CYP2D6—Alzheimer's disease	0.00205	0.0241	CbGpPWpGaD
Thiabendazole—CYP1A1—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00197	0.0232	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00192	0.0226	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.00189	0.0223	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—MAP2—Alzheimer's disease	0.00188	0.0222	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.00165	0.0195	CbGpPWpGaD
Thiabendazole—CYP1A1—Estrogen Receptor Pathway—ESR1—Alzheimer's disease	0.00157	0.0185	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.00157	0.0185	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.00156	0.0184	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00155	0.0183	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—CYP2D6—Alzheimer's disease	0.00152	0.0179	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—MAOB—Alzheimer's disease	0.00141	0.0167	CbGpPWpGaD
Thiabendazole—CYP1A2—Xenobiotics—CYP2D6—Alzheimer's disease	0.0013	0.0154	CbGpPWpGaD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00125	0.0148	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00122	0.0144	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.00121	0.0142	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—SOD1—Alzheimer's disease	0.00114	0.0135	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—HMOX1—Alzheimer's disease	0.0011	0.013	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—ACHE—Alzheimer's disease	0.00105	0.0124	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—SOD2—Alzheimer's disease	0.00103	0.0121	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen Receptor Pathway—ESR1—Alzheimer's disease	0.001	0.0118	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.001	0.0118	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00099	0.0117	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—CYP2D6—Alzheimer's disease	0.000969	0.0114	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000927	0.0109	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000902	0.0106	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.00087	0.0102	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.000867	0.0102	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.00085	0.01	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000838	0.00988	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP46A1—Alzheimer's disease	0.000825	0.00972	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000814	0.00959	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000751	0.00884	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.00074	0.00872	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	0.000715	0.00842	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	0.00071	0.00836	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000702	0.00827	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000689	0.00811	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000639	0.00753	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000591	0.00696	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	0.000572	0.00674	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—CALM1—Alzheimer's disease	0.000555	0.00653	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—APOE—Alzheimer's disease	0.000553	0.00651	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000542	0.00638	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000535	0.0063	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP46A1—Alzheimer's disease	0.000526	0.0062	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000519	0.00611	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—MAOB—Alzheimer's disease	0.000492	0.0058	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—GSK3B—Alzheimer's disease	0.000479	0.00564	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000475	0.00559	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	0.000456	0.00537	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—ABCA1—Alzheimer's disease	0.000454	0.00534	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—Alzheimer's disease	0.000453	0.00533	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000448	0.00528	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—Alzheimer's disease	0.000444	0.00523	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000439	0.00517	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000424	0.00499	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	0.000411	0.00484	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—PPARGC1A—Alzheimer's disease	0.000391	0.00461	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000384	0.00453	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARGC1A—Alzheimer's disease	0.000383	0.00451	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	0.000382	0.0045	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—PTGS1—Alzheimer's disease	0.000373	0.0044	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2D6—Alzheimer's disease	0.000366	0.00431	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	0.000365	0.0043	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000361	0.00425	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000343	0.00404	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	0.000323	0.00381	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000317	0.00373	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	0.000314	0.0037	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—Alzheimer's disease	0.000306	0.0036	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000303	0.00357	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	0.000297	0.0035	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	0.000277	0.00327	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	0.000277	0.00327	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARGC1A—Alzheimer's disease	0.000264	0.00311	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	0.000262	0.00308	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—PPARG—Alzheimer's disease	0.00026	0.00306	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Alzheimer's disease	0.000254	0.003	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000245	0.00289	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	0.000244	0.00287	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	0.000238	0.0028	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	0.000233	0.00275	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.00023	0.00271	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000219	0.00258	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—DHCR24—Alzheimer's disease	0.000211	0.00249	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	0.000206	0.00243	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000202	0.00238	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000197	0.00232	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	0.000189	0.00223	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CA4—Alzheimer's disease	0.00018	0.00212	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	0.000177	0.00208	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	0.000177	0.00208	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000176	0.00207	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Alzheimer's disease	0.000175	0.00206	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GAPDHS—Alzheimer's disease	0.000169	0.00199	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ATP5A1—Alzheimer's disease	0.00016	0.00189	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLD3—Alzheimer's disease	0.000153	0.0018	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000153	0.0018	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000151	0.00178	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSD17B10—Alzheimer's disease	0.000147	0.00173	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000143	0.00169	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP46A1—Alzheimer's disease	0.000141	0.00166	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ND1—Alzheimer's disease	0.000136	0.00161	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	0.000135	0.00159	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000133	0.00157	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000126	0.00148	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000122	0.00144	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CA4—Alzheimer's disease	0.000115	0.00135	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000112	0.00132	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	0.000108	0.00127	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000105	0.00124	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	0.000102	0.0012	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLD3—Alzheimer's disease	9.75e-05	0.00115	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	9.75e-05	0.00115	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	9.64e-05	0.00114	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9.56e-05	0.00113	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	9.35e-05	0.0011	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	9.13e-05	0.00108	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	9e-05	0.00106	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TPI1—Alzheimer's disease	8.78e-05	0.00103	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CHAT—Alzheimer's disease	8.78e-05	0.00103	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ND1—Alzheimer's disease	8.69e-05	0.00102	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	8.49e-05	0.001	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MAOB—Alzheimer's disease	8.42e-05	0.000992	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GAPDH—Alzheimer's disease	8.1e-05	0.000955	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.01e-05	0.000944	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.94e-05	0.000935	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—A2M—Alzheimer's disease	7.83e-05	0.000922	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	7.77e-05	0.000915	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.98e-05	0.000822	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ACHE—Alzheimer's disease	6.81e-05	0.000802	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—INPP5D—Alzheimer's disease	6.73e-05	0.000793	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	6.69e-05	0.000789	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS1—Alzheimer's disease	6.38e-05	0.000752	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ENO1—Alzheimer's disease	6.38e-05	0.000752	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2D6—Alzheimer's disease	6.26e-05	0.000737	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	6.09e-05	0.000718	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BCHE—Alzheimer's disease	5.93e-05	0.000699	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TPI1—Alzheimer's disease	5.6e-05	0.00066	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CHAT—Alzheimer's disease	5.6e-05	0.00066	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	5.6e-05	0.000659	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.49e-05	0.000647	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	5.43e-05	0.000639	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MAOB—Alzheimer's disease	5.37e-05	0.000632	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	5.17e-05	0.000609	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.11e-05	0.000602	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.06e-05	0.000596	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—A2M—Alzheimer's disease	4.99e-05	0.000588	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	4.68e-05	0.000551	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	4.65e-05	0.000548	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.45e-05	0.000524	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ACHE—Alzheimer's disease	4.34e-05	0.000511	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	4.29e-05	0.000506	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LPL—Alzheimer's disease	4.26e-05	0.000502	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ENO1—Alzheimer's disease	4.07e-05	0.000479	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	4.07e-05	0.000479	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	3.99e-05	0.00047	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	3.83e-05	0.000452	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BCHE—Alzheimer's disease	3.78e-05	0.000446	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CALM1—Alzheimer's disease	3.58e-05	0.000422	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	3.57e-05	0.00042	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APOE—Alzheimer's disease	3.57e-05	0.00042	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAV1—Alzheimer's disease	3.54e-05	0.000417	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.5e-05	0.000412	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	3.46e-05	0.000408	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARG—Alzheimer's disease	3.11e-05	0.000366	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—INS—Alzheimer's disease	3.05e-05	0.000359	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.98e-05	0.000351	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.97e-05	0.00035	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.71e-05	0.00032	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NOS3—Alzheimer's disease	2.67e-05	0.000315	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	2.45e-05	0.000288	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.44e-05	0.000288	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.28e-05	0.000269	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.28e-05	0.000268	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.25e-05	0.000266	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.98e-05	0.000233	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—INS—Alzheimer's disease	1.94e-05	0.000229	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.7e-05	0.000201	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.56e-05	0.000184	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKT1—Alzheimer's disease	1.23e-05	0.000145	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKT1—Alzheimer's disease	7.84e-06	9.23e-05	CbGpPWpGaD
